The notices it replaced
- Reissues: PAR-21-115 Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,097,764 in first-year total cost, median $693,471.
Most frequent study sections
- Child Psychopathology and Developmental Disabilities Study Section[CPDD]1
- Special Emphasis Panel[ZRG1 MGG-A (02)]1
- Therapeutic Approaches to Genetic Diseases Study Section[TAG]1
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF COLORADO DENVER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Natural History of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD), a Heritable Disorder of GABA Metabolism2R01HD091142-06A1 · under PAR-21-115 | PEARL, PHILLIP LAWRENCE | BOSTON CHILDREN'S HOSPITAL, MA | $738,814 | TAG |
| 2024 | Characterizing the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS): a fundamental step in the development of a targeted cure for this novel atypical sphingolipidosis1R01HD113778-01 · under PAR-21-115 | SABA, JULIE D | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $693,471 | ZRG1 |
| 2023 | The eXtraordinarY Babies Study: Natural History of Health and Neurodevelopment in Infants with Sex Chromosome Trisomy2R01HD091251-06A1 · under PAR-21-115 | TARTAGLIA, NICOLE RENEE | UNIVERSITY OF COLORADO DENVER, CO | $665,479 | CPDD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.